Skip to main content
. Author manuscript; available in PMC: 2021 May 25.
Published in final edited form as: Leuk Lymphoma. 2016 Nov 10;58(6):1481–1487. doi: 10.1080/10428194.2016.1246733

Figure 1.

Figure 1.

CYTO-PV study prospective comparison of treatment arms for strict versus lenient hematocrit control at 6 months and twelve months (N = 224). (A) Comparison of the six and twelve month scores for individuals randomized to lower hematocrit control. (B) Six and 12 month symptom scores among participants randomized to elevated hematocrit goal.